Herbas VPB

Print
EN | LT
Supplementary protection
LT - Chimeriniu antigenų receptoriumi modifikuotų ląstelių naudojimas vėžio gydymui
EN - USE OF CHIMERIC ANTIGEN RECEPTOR-MODIFIED T CELLS TO TREAT CANCER
SPC
(11) Number of the document C 2649086
(68) Number of the document 2649086
(21) Application number for Supplementary Protection Certificate PA 2019 502
(22) Date of filing the application 2019-02-15
(41) Date of publication of the application 2019-03-12
Date of publication of SPC 2020-12-28
(24) Date of coming into effect of SPC 2031-12-10
Applicant
(71) The Trustees of The University of Pennsylvania, Center for Technology Transfer 3160 Chestnut Street, Suite 200, Philadelphia PA 19104-6283, US
Grantee
(73) The Trustees of The University of Pennsylvania, Center for Technology Transfer 3160 Chestnut Street, Suite 200, Philadelphia PA 19104-6283, US
Attorney or representative
(74) Jurga PETNIŪNAITĖ, AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius, LT
Number, date and code of the country of origin of the first authorization to place the medicinal or plant protection product on the market within regional economic community
(93) EU/1/18/1297, 2018-08-23
Calculated date of expiry of the SPC
(94) 2033-08-27
Name of the product protected by the basic patent
(95) Tisagenlekleucelas
Legal status
SPC granted
Last update date 2021-11-25